title: Quantification of rimonabant (SR 141716A) in monkey plasma using HPLC with UV detection.
abstract: Using an isocratic high-performance liquid chromatography (HPLC) system and UV detection, a simple and precise analytical procedure was developed to quantify levels of the CB(1) receptor antagonist rimonabant in the plasma of rhesus monkeys. Rimonabant was extracted from plasma samples into 5% isopropanol in hexane. After separation, the isopropanol-hexane fractions were dried to residue, redissolved in mobile phase, and then injected into the HPLC. The HPLC system included an acetonitrile-phosphate buffer (62:38, v/v) mobile phase (pH 6.7), flow rate of 1.5 mL/min, C(18) column (4.6 mm i.d. x 150 mm length, 5 microm), and UV detection at 280 nm. Retention times for rimonabant and doxepin (internal standard) were 9.9 and 2.4 min, respectively. The regression of the spiked calibrator curve was linear from 60 to 4000 ng/mL (r(2) = 0.996). The lower limit of quantification was 60 ng/mL, and recovery was 83.6%. Rimonabant was stable in stock solutions and monkey plasma across a range of temperatures and concentrations. To demonstrate utility, plasma rimonabant was measured in six rhesus monkeys at 60 and 240 min after intramuscular administration of 1 mg/kg rimonabant. Rimonabant levels ranged from 175 to 1290 ng/mL. The analytical assay described here provides a simple and accurate procedure for multiple within-subject measurements of the CB(1) antagonist rimonabant.
authors.affiliation: Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, USA. javors@uthscsa.edu
authors.forename: Martin A
authors.initials: MA
authors.lastname: Javors
authors.forename: Jesus J
authors.initials: JJ
authors.lastname: Sanchez
authors.forename: Lance R
authors.initials: LR
authors.lastname: McMahon
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004316:Doxepin / Q000032:analysis / Q000737:chemistry; D005260:Female; D016014:Linear Models; D008253:Macaca mulatta / Q000097:blood*; D008297:Male; D010880:Piperidines / Q000097:blood* / Q000737:chemistry; D011720:Pyrazoles / Q000097:blood* / Q000737:chemistry; D015203:Reproducibility of Results; D000077285:Rimonabant; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet / Q000379:methods*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D004316:Doxepin; D000077285:Rimonabant
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 1;863(2):258-65
references.pmid: 18258497
references.citation: Psychopharmacology (Berl). 2001 Aug;156(4):369-80
references.pmid: 11498713
references.citation: Behav Pharmacol. 2005 Sep;16(5-6):275-96
references.pmid: 16148435
references.citation: Anal Chem. 2007 Aug 1;79(15):5668-73
references.pmid: 17605466
references.citation: Life Sci. 1995;56(23-24):1941-7
references.pmid: 7776817
references.citation: Arch Gen Psychiatry. 2001 Apr;58(4):322-8
references.pmid: 11296091
references.citation: FEBS Lett. 1994 Aug 22;350(2-3):240-4
references.pmid: 8070571
references.citation: Psychopharmacology (Berl). 2006 Oct;188(3):306-14
references.pmid: 16953389
references.citation: Nat Neurosci. 2000 Nov;3(11):1073-4
references.pmid: 11036260
references.citation: Drug Metab Dispos. 2005 Apr;33(4):508-17
references.pmid: 15616153
references.citation: Psychopharmacology (Berl). 2007 May;192(1):135-45
references.pmid: 17245585